BCL2 and hepatocellular carcinoma: This was accomplished while boosting therapeutic potential in SMMC-7721 cells by modulating apoptotic pathways via increased production of Bax and caspase-3 and reduced levels of Bcl-2; thus, it can play an important role in the treatment of hepatocellular carcinoma [73].